Stock Information
Viridian Therapeutics Inc (VRDN)
Ticker Symbol: VRDN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,804.09 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.9999
Revenue (TTM): $0.75 M
Dividend Yield: N/A%
ROE: -58.44%
Latest News
-
This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know
Sat, Mar 21, 2026 10:33 PM
-
Is It Too Late To Consider Viridian Therapeutics (VRDN) After Its 82% One-Year Surge?
Fri, Mar 20, 2026 6:07 PM
-
Bambusa Therapeutics Appoints Todd James Chief Financial Officer
Thu, Mar 19, 2026 12:30 PM
-
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit
Wed, Mar 18, 2026 6:08 PM
-
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
Wed, Mar 18, 2026 5:54 PM
Key Financials
Financial data not available
